The short answer: nobody knows, because no published study has tested alcohol and retatrutide together in people. There's no label to check either, since retatrutide isn't approved.
What exists is nearby evidence. The tirzepatide and semaglutide labels never mention drinking, but they warn about pancreatitis and dehydration, and alcohol feeds into both. Separately, early research suggests this drug family may reduce drinking.
Status as of November 6, 2026: Retatrutide is investigational and not approved by the FDA or any regulator. Lilly plans to file for U.S. approval in Q1 2027. Nothing here is medical advice, a dosing guide or a safe-drinking limit.
Key takeaways
No human alcohol data exists for retatrutide. The only published alcohol experiment I found used rats.
The phase 2 trial excluded heavy drinkers: more than 14 units a week for women, more than 21 for men.
The Zepbound, Mounjaro, Wegovy and Ozempic labels don't mention drinking alcohol at all.
In a 108-person Lancet trial, semaglutide cut heavy drinking days by 41.1 percentage points vs 26.4 on placebo, in people with alcohol use disorder and obesity.
Lilly has finished a 308-person alcohol use disorder trial of a related drug, mazdutide. No results are posted.
Want the short version of what's actually approved, legal and tested? Get the free BHN cheat sheet.
Can you drink alcohol on reta?
There's no evidence-based answer yet. On November 6 I searched PubMed and pulled all 32 Lilly retatrutide records on ClinicalTrials.gov. None studies alcohol as a treatment target or an interaction. The rat study is the only retatrutide alcohol experiment that turned up (Windram et al., Psychopharmacology, 2026).
So any firm "one drink is fine" or "never touch it" for reta is reasoning from other drugs. This post does that too, and it says so.
Did the reta trials allow drinkers?
Some records screen for heavy drinking, but most don't list alcohol at all. Two of the 32 Lilly records name an alcohol limit. The phase 2 obesity trial says participants "must not drink excessive amounts of alcohol (more than 14 units a week for women or more than 21 units a week for men)" (ClinicalTrials.gov, NCT04881760). A Chinese obesity trial used the same numbers (ClinicalTrials.gov, NCT05548231). Neither record defines a "unit."
The TRIUMPH-1 record lists no alcohol rule (ClinicalTrials.gov, NCT05929066). Registry entries are summaries, though, and the full protocol may say more.
Pancreatitis is the more common screen: 19 of the 32 records exclude people with a history of it.
What do the tirzepatide and semaglutide labels say about alcohol?
Nothing about drinking it. I searched the full current labels. The word "alcohol" appears only as an ingredient (benzyl alcohol), in injection instructions (alcohol swabs) or in a liver disease name.
Label | Mentions drinking alcohol? | Pancreatitis warning? | Dehydration and kidney warning? |
|---|---|---|---|
No | Yes | Yes | |
No | Yes | Yes | |
No | Yes | Yes | |
No | Yes | Yes |
Silence isn't clearance. None of the four lists alcohol use disorder as a use, either.
Does reta make you want to drink less?
Unknown in people. In rats, single doses of semaglutide, tirzepatide and retatrutide each blunted how the animals perceived alcohol (Windram et al., 2026). That's a rat study of perception, not drinking in humans.
The human evidence comes from other drugs, and it's mixed but improving:
Study | Drug | Who | Result |
|---|---|---|---|
Semaglutide, 26 weeks, plus therapy | 108 people with alcohol use disorder and obesity | Heavy drinking days fell 41.1 points vs 26.4 on placebo | |
Semaglutide, 9 weeks | 48 people with alcohol use disorder | Less craving and fewer drinks per drinking day. No change in drinking days | |
Exenatide, 26 weeks | 127 people with alcohol use disorder | No overall drop in heavy drinking days. Exploratory signal with BMI over 30 | |
Semaglutide or tirzepatide vs SGLT2 drugs | Health records, adults with type 2 diabetes | Fewer alcohol-related hospital or ER visits: hazard ratio 0.54 and 0.61. Observational |
The trials enrolled people with alcohol use disorder. They don't tell you what two drinks on Saturday do.
Lilly is testing this directly, just not with retatrutide:
Mazdutide (NCT06817356). A GLP-1 and glucagon dual agonist (NEJM, 2025), so it shares two of reta's three targets. This phase 2 trial in alcohol use disorder finished with 308 people. Primary completion was March 2026. No results are posted (ClinicalTrials.gov).
Brenipatide (RENEW-ALC-1 and RENEW-ALC-2). A separate Lilly drug. Two phase 3 trials in alcohol use disorder, about 1,100 people each, are recruiting, with estimated completion in April 2028 (NCT07219966, NCT07219953).
When Lilly's mazdutide alcohol results land, I'll update this post. Get them by email.
Will alcohol hit harder or slower on reta?
Nobody has measured it on reta. The closest human data suggests a slower rise, not a smaller one.
Alcohol is absorbed mainly past the stomach, so a drug that slows stomach emptying could delay it. A 2023 paper reports that retatrutide "delays gastric emptying" (Diabetes Obes Metab, 2023). In a pilot of 20 adults with obesity, 10 of them on semaglutide, tirzepatide or liraglutide, breath alcohol rose more slowly in the drug group for about 20 minutes. They also felt less drunk early on. By one hour, breath alcohol wasn't different from controls (Quddos et al., Sci Rep, 2025).
That study wasn't randomized, and nobody in it took reta. My read, not a finding: a late buzz isn't room for another drink.
Where do reta side effects and alcohol overlap?
Stomach, fluids, heart rate and blood sugar. No study has measured these together on reta, so this table only sets separate facts side by side.
Issue | Reta or a close relative | Alcohol |
|---|---|---|
Nausea, vomiting | TRIUMPH-1, 12 mg: nausea 42.4% vs 14.8% placebo, vomiting 25.3% vs 4.8% | "Directly irritates the lining of the stomach and increases acid release" |
Fluid loss | Zepbound label: most kidney injury reports involved "dehydration such as nausea, vomiting, or diarrhea" | "Increases urination and excess loss of fluids" |
Heart rate | Phase 2, 12 mg, week 48: +6.0 bpm vs +0.4 on placebo | 25.9% of 3,028 Octoberfest drinkers had sinus tachycardia, a fast heart rhythm |
Low blood sugar | Zepbound label: 10.3% with a sulfonylurea vs 2.1% without, in type 2 diabetes. | Makes blood sugar harder to hold steady, "especially if you haven't eaten in a while" |
Sources: Lilly, June 6, 2026, Zepbound label, Zhang et al., 2026, NIAAA, MunichBREW, Eur Heart J, 2017, NIDDK.
Again reasoning, not data: the overlap is biggest when you're already nauseous, vomiting or barely eating. More in is reta safe? and does reta raise your heart rate?
Does alcohol raise pancreatitis risk on reta?
Unknown for the combination, but this is the overlap to take most seriously. Each risk is documented on its own.
The drugs. All four labels warn that acute pancreatitis, "including fatal and non-fatal hemorrhagic or necrotizing pancreatitis," has been seen with this class (Zepbound label).
Retatrutide. 19 of the 32 Lilly records exclude people with a history of pancreatitis, so the trials say little about that group.
Alcohol. NIDDK lists heavy alcohol use among the most common causes of both acute and chronic pancreatitis (NIDDK).
The label's warning sign is persistent or severe abdominal pain, sometimes reaching the back, with or without vomiting. On Zepbound, the instruction is to stop the drug and call your provider right away. Treat that as urgent, not as a hangover.
Can you drink beer on reta?
Same answer as any alcohol: untested. A 12-ounce regular beer at 5% counts as one standard drink, 14 grams of pure alcohol, the same as other standard drinks (NIAAA). So beer isn't a safer loophole.
The one beer-specific thought is fizz. Burping, bloating and reflux are on the Wegovy label (Wegovy label), so a big carbonated drink may sit badly. That's inference, not data.
Can you drink coffee on reta?
Nothing published says you can't, and nothing says what happens if you do. The labels don't mention coffee or caffeine. No Lilly record lists caffeine as an exclusion.
The odd part: Lilly has measured it. A 32-person drug interaction study gave participants caffeine, along with midazolam and warfarin, to see how retatrutide changed their blood levels. It finished in February 2023, and no results are posted (ClinicalTrials.gov, NCT05445232). The data exists, and you can't read it.
What's known around it:
The FDA's general figure is 400 mg of caffeine a day for most adults. Too much can cause increased heart rate, palpitations, upset stomach and nausea (FDA, 2024). That list overlaps with reta's side effects.
Coffee and the heart. In a 100-person randomized trial of adults not on these drugs, coffee days had 154 premature ventricular contractions vs 102 on no-caffeine days, and 36 fewer minutes of sleep. Atrial beats didn't rise significantly (NEJM, 2023).
Who should be most careful with alcohol on reta?
Going by the labels and trial exclusions, raise it with a doctor first if you're one of these:
Anyone with a history of pancreatitis. Most reta trials excluded them, so there's no data for you.
Heavy drinkers. The phase 2 trial excluded you. Don't treat reta as a drinking treatment. None of the four labels lists that use, and reta has never been tested for it.
People on insulin or a sulfonylurea. Both the drug class and alcohol push toward low blood sugar.
People on blood pressure medication. In TRIUMPH-2, low blood pressure showed up in 6% at 12 mg vs under 1% on placebo (Lancet, 2026).
All the reta data above is Lilly's own drug. None of it covers what's in a vial from anywhere else.
Alcohol on reta FAQ
Is it safe to drink on retatrutide?
Nobody can say. No study has tested the combination in people, and retatrutide has no label.
Does retatrutide stop alcohol cravings?
There's no human data. Retatrutide blunted how rats perceived alcohol in one study. Semaglutide reduced craving in a 48-person trial, but that's a different drug.
Can you get drunk faster on reta?
Unmeasured. In a 20-person pilot on other GLP-1 drugs, breath alcohol rose more slowly at first and matched controls by one hour. A delayed buzz doesn't mean less alcohol.
Does Zepbound or Wegovy say to avoid alcohol?
No. Their current labels don't mention drinking alcohol. They do warn about acute pancreatitis and about kidney injury tied to dehydration.
Is Lilly testing retatrutide for alcohol use disorder?
Not in any of the 32 Lilly records I checked on November 6. Lilly is testing two other drugs for it: mazdutide in a finished phase 2 trial with no posted results, and brenipatide in two phase 3 trials.
Does caffeine interact with reta?
Unknown publicly. Lilly ran a 32-person study that measured caffeine levels on retatrutide, but no results are posted. The FDA's general figure for most adults is 400 mg a day.
Want the short version of what's actually approved, legal and tested? Get the free BHN cheat sheet.
If you've noticed alcohol or coffee hitting differently on a GLP-1 drug, reply and tell me what changed. I'll keep reader reports labeled as reports, separate from the data.
Sources
ClinicalTrials.gov: NCT04881760, NCT05548231, NCT05929066, NCT05445232, NCT06817356, NCT07219966, NCT07219953